A Comparative Pharmacokinetics Study of the Anti-Parkinsonian Drug Pramipexole

A Comparative Pharmacokinetics Study of the Anti-Parkinsonian Drug Pramipexole

The present study aimed to compare pharmacokinetic parameters of two pramipexole 0.25 mg formulations in order to show bioequivalence. The study was conducted in a randomized, open-label, two-period, two-sequence, and crossover design, involving 23 healthy volunteers. One of the 0.25 mg formulations...

Full description

Bibliographic Details
Main Authors: Ratih S. I. Putri, Effi Setiawati, Syifa A. Aziswan, Fenny Ong, Raymond R. Tjandrawinata, Liana W. Susanto
Format: Article
Language:English
Published: Österreichische Apotheker-Verlagsgesellschaft m. b. H. 2016-11-01
Series:Scientia Pharmaceutica
Subjects:
bioavailability
bioequivalence
Parkinson’s disease
pharmacokinetics
pramipexole
Online Access:http://www.mdpi.com/2218-0532/84/4/715

Internet

http://www.mdpi.com/2218-0532/84/4/715

Similar Items